{
    "Trade/Device Name(s)": [
        "MEG-2 Blood Glucose Monitoring System",
        "MEG-2 Blood Glucose Test Strips",
        "MEG-2 Glucose Control Solutions",
        "MEG-2 Multi Blood Glucose Monitoring System",
        "MEG-2 Multi Blood Glucose Test Strips"
    ],
    "Submitter Information": "Apex BioTechnology Corp.",
    "510(k) Number": "K101204",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW",
        "JJX"
    ],
    "Summary Letter Date": "August 19, 2011",
    "Summary Letter Received Date": "August 22, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1345",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose Test System",
        "Single (Specified) Analyte Controls (Assayed and Unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "MEG-2 Blood Glucose Meter",
        "MEG-2 Multi Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Monitoring System",
        "Test Strips",
        "Control Solutions",
        "Meter"
    ],
    "Document Summary": "FDA 510(k) summary for MEG-2 and MEG-2 Multi Blood Glucose Monitoring Systems and accessories for quantitative measurement of glucose in capillary whole blood",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertip, forearm, or palm for self-testing by lay users and multi-patient clinical use by professionals as an aid in monitoring levels in Diabetes Mellitus; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}